Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?
Open Access
Abstract
Malignant Mesothelioma (MM) is an aggressive neoplasm of the pleural mesothelium, less frequently peritoneal and exceptionally of the vaginal tunic of the testicle and pericardiumKeywords
This publication has 6 references indexed in Scilit:
- Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug ResponseCancers, 2022
- New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural MesotheliomaCancers, 2021
- Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of MesotheliomaCancers, 2021
- NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaCancers, 2021
- C1q–HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 ExpressionCancers, 2021
- Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma PatientsCancers, 2020